# Nobel prize 2026 physiology and medicine - Manipulating Living Cells with Light **URL:** \ **Category:** General\ **Created:** [October 8, 2026, 3:01pm UTC](https://www.medboundhub.com/t/nobel-prize-2026-physiology-and-medicine-manipulating-living-cells-with-light/23769 "2026-10-08T15:01:16Z")\ **Posts on this page:** 2\ **Page:** 1
**Author:** ![Lizanne](https://yyz1.discourse-cdn.com/flex033/user_avatar/www.medboundhub.com/lizanne/32/4721_2.png) [@Lizanne](https://www.medboundhub.com/u/Lizanne)\ **Post date:** [October 8, 2026, 3:01pm UTC](https://www.medboundhub.com/t/nobel-prize-2026-physiology-and-medicine-manipulating-living-cells-with-light/23769/1 "2026-10-08T15:01:16Z")
![Optogenics](https://canada1.discourse-cdn.com/flex033/uploads/medbound/original/2X/9/9eaaca73119ab3b7c435bbd6ac5a75e0965e4b51.jpeg) The word **optogenetics** has taken on new significance following the announcement of the 2026 Nobel Prize in Physiology or Medicine, awarded jointly to Peter Hegemann, Georg Nagel, and Karl Deisseroth for discoveries leading to optogenetics. Their work established a powerful approach for controlling nerve cell activity using light. **What is Optogenetics?** Optogenetics is a biological technology that combines genetic engineering and optical stimulation to induce or inhibit well-defined events in tissue or cells with high spatial and temporal precision. **What is the principle of optogenetics?** Optogenetics involves three core features: the microbial opsin, methods for targeting cell populations, and methods for light delivery. Opsins are membrane-bound proteins activated by light. These were first discovered in _[Chlamydomonas reinhardtii](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/chlamydomonas-reinhardtii "Learn more about Chlamydomonas reinhardtii from ScienceDirect's AI-generated Topic Pages")_, a unicellular green alga. Their stimulation can result in cell activation, inhibition or modulation. Researchers can obtain these opsins from microbes or bioengineer them to have specific properties. The specific constructed opsin is incorporated into the desired cell types under the control of a promoter. Light must be delivered in a targeted manner to control the opsin-expressing cells. Researchers have used different light sources, such as blue and green lasers, light-emitting diode sources and other commercially available light delivery systems. These systems are typically paired with software that allows for adjustment of intensity, frequency, and duration of light delivery, as different cell types may require different activation frequencies. When one knows the characteristics of the target cell population, it can be possible to mimic certain aspects of “normal” physiological activity. **Applications of Optogenetics in medicine** 1. Neurology Optogenetics has found numerous applications in the field of neurology, including the investigation of animal behaviour, optic nerve pathways, and treatment of neurological disorders such as Alzheimer’s disease, stroke, pain management, and the role of peripheral nerves, among others. Vision restoration is one of the most advanced examples of direct clinical application, with optogenetic strategies being investigated to restore light sensitivity in retinal degenerative diseases where conventional photoreceptors have been lost. 1. Cardiology Heart light genetics has been gaining popularity over the last decade as a tool for research on cardiac function and evaluation of the function of the myocardial cells. It has also shown feasibility in the treatment of several heart diseases. For instance, cardiac pacemakers using light stimulation to control pulse rate and painless defibrillation using light genetics. Additionally, cardiac resynchronisation therapy utilising diffuse light and protein expression has the potential to influence an unlimited number of remote sites. 1. Metabolism Engineered light-sensitive systems are increasingly being used to manipulate intracellular signalling, ion gradients, organelle function and metabolic pathways. Researchers have explored optogenetic systems in metabolomics, including the regulation of glucagon secretion for blood glucose homeostasis, promotion of insulin expression, and development of microbial fermentation production. This could have implications for research into metabolic disorders, endocrine biology, drug discovery and synthetic biology. 1. Cancer research Immunotherapy has been hampered by the immunosuppressive microenvironment surrounding solid tumours. Optogenetic tools can be used to manipulate signalling pathways, protein interactions, gene expression and cellular behaviour with exceptional temporal control. In cancer research, this allows investigators to study how specific signalling pathways contribute to tumour growth, invasion, immune evasion and interactions within the tumour microenvironment. Optogenetic approaches are also being investigated for controlling immune-cell behaviour and improving the precision of cell-based therapeutic strategies. **The road ahead** For clinicians, pharmacists, and biotechnology professionals, the real promise of optogenetics lies not only in what it can control today, but in what it could make possible tomorrow. **How precisely can we use Optogenetics to improve human health?** MBH/PS ---
**Author:** ![vidhi12](https://yyz1.discourse-cdn.com/flex033/user_avatar/www.medboundhub.com/vidhi12/32/5945_2.png) [@vidhi12](https://www.medboundhub.com/u/vidhi12)\ **Post date:** [October 8, 2026, 5:30pm UTC](https://www.medboundhub.com/t/nobel-prize-2026-physiology-and-medicine-manipulating-living-cells-with-light/23769/2 "2026-10-08T17:30:31Z")
This research can open doors for discovery of multiple treatment options for diseases like epilepsy, parkinson’s and vision loss.